Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Operations

v3.7.0.1
Condensed Consolidated Statements Of Operations - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2017
Mar. 31, 2016
Condensed Consolidated Statements Of Operations [Abstract]        
Net revenues $ 2,405,519 $ 4,772,801 $ 5,649,118 $ 13,003,460
Cost of sales 1,127,864 1,927,406 2,719,179 4,755,728
Gross profit 1,277,655 2,845,395 2,929,939 8,247,732
Operating expenses:        
Selling, general and administrative 2,419,826 2,739,850 5,775,700 5,711,337
Research and development 1,437,062 35,120 1,608,162 73,415
Total operating expenses 3,856,888 2,774,970 7,383,862 5,784,752
Operating (loss) income (2,579,233) 70,425 (4,453,923) 2,462,980
Non-operating expenses:        
Interest and other expense, net (12,686) (19,356) (22,307) (47,152)
Foreign currency transaction loss (8,756) (43,848) (20,695) (88,791)
Total non-operating expenses (21,442) (63,204) (43,002) (135,943)
(Loss) Income before income taxes (2,600,675) 7,221 (4,496,925) 2,327,037
Income tax (benefit) expense (824,033) (27,824) (1,354,102) 801,629
Net (loss) income $ (1,776,642) $ 35,045 $ (3,142,823) $ 1,525,408
Net (loss) income per basic common share outstanding $ (0.06) $ 0.00 $ (0.10) $ 0.05
Basic weighted average common shares outstanding 30,982,497 28,652,635 30,979,283 28,642,951
Net (loss) income per diluted common share outstanding $ (0.06) $ 0.00 $ (0.10) $ 0.05
Diluted weighted average common shares outstanding 30,982,497 29,059,296 30,979,283 29,046,928